September 21, 2023 | Advisors, AdvisoryBoard, DOL, HCP, KOL, Online advisory board, Pharma, Virtual advisory board, digital advisory board
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in mind:
5. Placement of Your Product in the Current and Future Treatment Algorithm
What are the current and potential places of your product in the treatment algorithm for specific patient populations? What factors (e.g. demographic, clinical, and regulatory/reimbursement factors, new data, or loss of exclusivity) may affect this?
Learn the other questions by reading our blog:
https://www.impetusdigital.com/2020/02/03/top-10-most-important-advisor-questions/
For more information on how we can help you engage your advisors, HCPs, patients, and stakeholders, visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Press ReleaseContact: Jess Masciangelo, Business Development Directorjmasciangelo@impetusdigital.commeetwithimpetus.comINSITE EVENT™ NAMED ONE OF THE MOST INNOVATIVE SERVICES OF 2020Toronto, ON, December 10, 2020 — Impetus Digital’s new virtual event platform InSite Event™...
Nance Dicciani &Â Denise Devine, Co-founders of RTM Vital Signs, join Natalie Yeadon, Co-Founder & CEO at Impetus Digital. We explore continuous ambulatory vital sign monitoring using wearable and implantable devices....
Bryn Williams-Jones, Professor & Director of the Bioethics Program at ESPUM and Editor-in-Chief of the Canadian Journal of Bioethics discusses the bioethical challenges of innovative healthcare technologies such as AI, digital therapeutics,...
Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...
Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...
Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...
Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...
Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...